India to procure over 30 crore COVID-19 vaccine doses per month by January

INTERNATIONAL DESK: The government sources on Saturday (October 16, 2021) said that the country will have a COVID-19 vaccine capacity of 28 crore doses this month, which includes 22 crore Serum Institute of Indias (SII) Covishield, 6 crore doses of Bharat Biotechs Covaxin and production of 60 lakh Zydus Cadila’s ZyCoV-D doses.

According to a report in ANI, India will have a capacity of more than 30 crores by next year per month, which includes Covishield, Covaxin, ZyCoV-D and Biological E vaccines.

The sources also revealed that the production of 60 lakh doses of Zydus Cadila`s ZyCoV-D, the third Indian company to make COVID-19 vaccines, is already ready with the company and Biological E will be submitting the data till November end of phase -3 trials.

In addition to Biological E, which will be providing 30 crore doses, another company that is expected to provide vaccine doses is Gennova. Gennova will be the fourth Indian company doing trials of mRNA vaccines. The country is expected to get Gennova`s mRNA vaccine doses by February.